Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
UPCOMING SESSIONS
in
ET
Tue, Nov 24, 2026
6:00 – 7:00 AM Bangkok
Understand Your Test Results: What They Mean and What to Ask Next
David Drew
Register
View all
UPCOMING SESSIONS
in
ET
Tue, Nov 24, 2026 · 6:00 – 7:00 AM Bangkok
Understand Your Test Results: What They Mean and What to Ask Next
David Drew
Register
View all sessions
All Upcoming Sessions
3
NOV
24
Understand Your Test Results: What They Mean and What to Ask Next
Tue, Nov 24, 2026 · 6:00 – 7:00 AM Bangkok
David Drew
Register
NOV
25
All Things Amyloid: Being a Caregiver - Finding My New Normal
Wed, Nov 25, 2026 · 9:00 – 9:00 AM Bangkok
Mackenzie Boedicker
Register
NOV
26
Navigating the Holidays While Living with a Rare or Chronic Illness
Thu, Nov 26, 2026 · 6:00 – 7:00 AM Bangkok
Krystal Griffin
Register
Providers
People
Therapeutics
Places
Home
Providers
Jan 23, 2026
AL Cardiac Amyloidosis Presenting as Grade 3 ATTR Mimicry on Scintigraphy
Read more
Jan 10, 2026
Cardiac Amyloidosis (ATTR-CM) Online Support Group
Read more
Dec 26, 2025
Screening for transthyretin amyloid cardiomyopathy in patients with musculoskeletal symptoms: Red flags in the rheumatology/orthopedics practice setting
Read more
Sep 11, 2019
Matt Millen Featured In Episode Of ‘The B1G Story’
Read more
Daniel John Matheson
Read more
BridgeBio
Read more
Alnylam® Pharmaceuticals
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi)…
Read more
Giada Bianchi, MD
Read more
Hereditary amyloidosis in Brazil: a focus on access to diagnosis and treatment
Read more
Paula Schmitt
Read more
Pagination
1
2
3
4
5
6
7
8
9
…
››
Next page
Last »
Last page
Subscribe to